SYS6002 compared to chemo for advanced cervical cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new drug called SYS6002 (an antibody-drug conjugate that targets cancer cells) against standard chemotherapy for cervical cancer that has spread or returned after prior treatment. The goal is to see if it can shrink tumors and help you live longer, possibly with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have cervical cancer that has spread or come back and that can't be removed by surgery or cured with radiation and chemo.
- You have already received a platinum chemotherapy (like cisplatin) and an immunotherapy (like a PD-1 or PD-L1 drug), and your cancer has gotten worse despite that treatment.
- You can provide a tumor tissue sample (old or new biopsy).
- Your cancer can be measured on imaging scans (like CT or MRI).
- You are generally in good health, with a daily activity level of 0 or 1, and are expected to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called 9MW2821 against standard chemotherapy options for cervical cancer that has come back or spread. The goal is to see if the new drug works better than the usual treatments, and you must have already tried a platinum-based chemotherapy.
This study tests a new drug called SYS6002 against standard chemotherapy for people with advanced bladder cancer that has grown after previous treatments. The goal is to see if SYS6002 can help slow the cancer better than chemotherapy.
This trial tests a new targeted drug (SYS6010) compared with standard single-drug treatments for advanced head and neck cancer that has not responded to previous therapies. The goal is to see if this new drug can shrink tumors or slow cancer growth better than the usual options.
This trial tests a new drug, SYS6090, combined with other treatments for advanced non-small cell or small cell lung cancer that has spread and can't be removed by surgery. It aims to see if this combination can help shrink or control the cancer, and how safe it is for patients.
This trial tests a new drug called SYS6040 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
This trial compares a new drug called SYS6010 to standard chemotherapy for people with a type of esophageal cancer that has progressed after initial treatment. It aims to see if SYS6010 is more effective and safe, potentially offering a new option for those who need it.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.